Your browser doesn't support javascript.
loading
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
Winther, Signe A; Henriksen, Peter; Vogt, Josef K; Hansen, Tue H; Ahonen, Linda; Suvitaival, Tommi; Hein Zobel, Emilie; Frimodt-Møller, Marie; Hansen, Tine W; Hansen, Torben; Parving, Hans-Henrik; Legido-Quigley, Cristina; Rossing, Peter; Pedersen, Oluf.
Afiliação
  • Winther SA; Steno Diabetes Center Copenhagen, Gentofte, Denmark. signe.abitz.winther@regionh.dk.
  • Henriksen P; Novo Nordisk A/S, Maaloev, Denmark. signe.abitz.winther@regionh.dk.
  • Vogt JK; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Hansen TH; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Ahonen L; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Suvitaival T; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Hein Zobel E; Biosyntia ApS, Copenhagen, Denmark.
  • Frimodt-Møller M; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Hansen TW; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Hansen T; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Parving HH; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Legido-Quigley C; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Rossing P; Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark.
  • Pedersen O; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Diabetologia ; 63(12): 2713-2724, 2020 12.
Article em En | MEDLINE | ID: mdl-32886190
ABSTRACT
AIMS/

HYPOTHESIS:

Abnormal gut microbiota and blood metabolome profiles have been reported both in children and adults with uncomplicated type 1 diabetes as well as in adults with type 1 diabetes and advanced stages of diabetic nephropathy. In this study we aimed to investigate the gut microbiota and a panel of targeted plasma metabolites in individuals with type 1 diabetes of long duration without and with different levels of albuminuria.

METHODS:

In a cross-sectional study we included 161 individuals with type 1 diabetes and 50 healthy control individuals. Individuals with type 1 diabetes were categorised into three groups according to historically measured albuminuria (1) normoalbuminuria (<3.39 mg/mmol); (2) microalbuminuria (3.39-33.79 mg/mmol); and (3) macroalbuminuria (≥33.90 mg/mmol). From faecal samples, the gut microbiota composition at genus level was characterised by 16S rRNA gene amplicon sequencing and in plasma a targeted profile of 31 metabolites was analysed with ultra HPLC coupled to MS/MS.

RESULTS:

Study participants were aged 60 ± 11 years (mean ± SD) and 42% were women. The individuals with type 1 diabetes had had diabetes for a mean of 42 ± 15 years and had an eGFR of 75 ± 25 ml min-1 (1.73 m)-2. Measures of the gut microbial beta diversity differed significantly between healthy controls and individuals with type 1 diabetes, either with micro- or macroalbuminuria. Taxonomic analyses showed that 79 of 324 genera differed in relative abundance between individuals with type 1 diabetes and healthy controls and ten genera differed significantly among the three albuminuria groups with type 1 diabetes. For the measured plasma metabolites, 11 of 31 metabolites differed significantly between individuals with type 1 diabetes and healthy controls. When individuals with type 1 diabetes were stratified by the level of albuminuria, individuals with macroalbuminuria had higher plasma concentrations of indoxyl sulphate and L-citrulline than those with normo- or microalbuminuria and higher plasma levels of homocitrulline and L-kynurenine compared with individuals with normoalbuminuria. Whereas plasma concentrations of tryptophan were lower in individuals with macroalbuminuria compared with those with normoalbuminuria. CONCLUSIONS/

INTERPRETATION:

We demonstrate that individuals with type 1 diabetes of long duration are characterised by aberrant profiles of gut microbiota and plasma metabolites. Moreover, individuals with type 1 diabetes with initial stages of diabetic nephropathy show different gut microbiota and plasma metabolite profiles depending on the level of albuminuria. Graphical abstract.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Albuminúria Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Albuminúria Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article